Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Three US executions...

    Three US executions delayed over lethal injection drug

    Farhat NasimWritten by Farhat Nasim Published On 2019-03-09T09:20:27+05:30  |  Updated On 9 March 2019 9:20 AM IST
    Three US executions delayed over lethal injection drug

    Chicago: The governor of the US state of Ohio on Thursday delayed three scheduled executions over concerns that a drug currently used in lethal injections could mimic the effects of "waterboarding," widely considered a form of torture.


    Governor Mike DeWine delayed executions scheduled as early as May, in line with a court ruling that using the controversial sedative midazolam could cause pain and suffering. The state is seeking alternatives.


    "Governor DeWine is issuing today's reprieves because it is highly unlikely that the state's new execution protocol, which is still in the process of being developed" would be ready for use by the scheduled execution dates, his office said in a statement.


    The governor's office cited federal Judge Michael Merz's January ruling that there was "good evidence that midazolam will cause the 'waterboarding' effects of pulmonary edema."


    Pulmonary edema is a medical term describing fluid buildup in the lungs. Waterboarding is an interrogation technique that simulates drowning.


    The reprieves affect convicted murderers Cleveland Jackson, Kareem Jackson and Gregory Lott.


    Midazolam has been the subject of numerous legal challenges, previously focused on the sedative not being strong enough to keep prisoner's unconscious during executions.


    Seven states have resorted to the drug as previously-used medications for lethal injections have become harder to obtain.


    Ohio halted its use of capital punishment in 2014, following the botched midazolam execution of Dennis McGuire, during which the inmate appeared to suffer, snorting and gasping for several minutes.


    Government officials since have insisted that increasing the drug's dosage has resolved the problem.


    Court rulings allowed executions in Ohio to proceed, including a federal appeals court decision in 2017 that endorsed a 50-times greater dose of midazolam.


    But concerns over the drug's use have persisted.


    Last year, a convict in Tennessee opted for the electric chair, instead of a three-drug protocol including midazolam.


    US Supreme Court Justice Sonia Sotomayor, in a dissent last year in another death penalty case, said using midazolam could cause "sensations of drowning, suffocating, and being burned alive from the inside out."


    "We have stopped being a civilized nation and accepted barbarism," if such an execution procedure is allowed to remain legal, she wrote.


    Also Read: NPPA revises ceiling prices of 14 drug formulations including Injections, Inhalators; Details

    CHICAGOdrugGovernor DeWinegovernor of CaliforniaJudge Michael MerzsKareem Jacksonlethal injection drugMike DeWineohiopainprotocolpulmonary edemasedativesedative midazolamsufferingtortureUSwaterboarding
    Source : AFP

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok